Statins: much more than just a lipid-lowering therapy.
Raja
Shahzad G
SG
Alder Hey Hospital, Liverpool and Harefield Hospital, Middlesex, United Kingdom. drrajashahzad@hotmail.com
Dreyfus
Gilles D
GD
D000544:Alzheimer Disease / Q000188:drug therapy; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy; D000069059:Atorvastatin; D009202:Cardiomyopathies / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000139:chemically induced / Q000209:etiology; D006538:Heptanoic Acids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D008268:Macular Degeneration / Q000188:drug therapy; D009103:Multiple Sclerosis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D017035:Pravastatin / Q000009:adverse effects / Q000627:therapeutic use; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use; D019821:Simvastatin / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin; D017035:Pravastatin